Tuberculosis Screening in Patients with Psoriasis Receiving Biologic Therapy: A Retrospective Cohort Study

被引：3
作者：
Snast, Igor [1 ]
Bercovici, Einav [1 ]
Avni, Tomer [2 ]
Shitenberg, Dorit [3 ]
Hodak, Emmilia [1 ,4 ]
Pavlovsky, Lev [1 ]
机构：
[1] Beilinson Med Ctr, Rabin Med Ctr, Dept Dermatol, IL-4941492 Petach Tikwa, Israel
[2] Beilinson Med Ctr, Rabin Med Ctr, Unit Infect Dis, IL-4941492 Petach Tikwa, Israel
[3] Beilinson Med Ctr, Rabin Med Ctr, Pulm Inst, IL-4941492 Petach Tikwa, Israel
[4] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel
来源：
ACTA DERMATO-VENEREOLOGICA | 2018年 / 98卷 / 10期
关键词：
INFECTION;
D O I：
10.2340/00015555-3007
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
[No abstract available]
引用
收藏
页码：979 / 980
页数：2
相关论文
共 10 条
  • [1] Reactivation of Tuberculosis in Three Cases of Psoriasis after Initiation of Anti-TNF Therapy
    Abu Shaikha, Samya
    Mansour, Khalid
    Riad, Hassan
    [J]. CASE REPORTS IN DERMATOLOGY, 2012, 4 (01): : 41 - 46
  • [2] Isoniazid toxicity and TB development during biological therapy of patients with psoriasis in Colombia
    Catano, Juan
    Morales, Milena
    [J]. JOURNAL OF DERMATOLOGICAL TREATMENT, 2016, 27 (05) : 414 - 417
  • [3] Management of long-term therapy with biological drugs in psoriatic patients with latent tuberculosis infection in real life setting
    Conti, Andrea
    Piaserico, Stefano
    Gisondi, Paolo
    Odorici, Giulia
    Galdo, Giovanna
    Lasagni, Claudia
    Pellacani, Giovanni
    [J]. DERMATOLOGIC THERAPY, 2017, 30 (05)
  • [4] National Psoriasis Foundation consensus statement on screening for latent tuberculosis infection in patients with psoriasis treated with systemic and biologic agents
    Doherty, Sean D.
    Van Voorhees, Abby
    Lebwohl, Mark G.
    Korman, Neil J.
    Young, Melodie S.
    Hsu, Sylvia
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2008, 59 (02) : 209 - 217
  • [5] Farhat M, 2006, INT J TUBERC LUNG D, V10, P1192
  • [6] Tuberculosis screening in patients with psoriasis before antitumour necrosis factor therapy: comparison of an interferon-γ release assay vs. tuberculin skin test
    Laffitte, E.
    Janssens, J. P.
    Roux-Lombard, P.
    Thielen, A. M.
    Barde, C.
    Marazza, G.
    Panizzon, R. G.
    Saurat, J-H.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2009, 161 (04) : 797 - 800
  • [7] Prevalence of latent tuberculosis infection in patients with moderate to severe psoriasis taking biologic therapies in a dermatologic private practice in Miami, Florida
    Medina-Gil, Carolina
    Dehesa, Luis
    Vega, Adriane
    Kerdel, Francisco
    [J]. INTERNATIONAL JOURNAL OF DERMATOLOGY, 2015, 54 (07) : 846 - 852
  • [8] British Association of Dermatologists guidelines for biologic therapy for psoriasis 2017
    Smith, C. H.
    Jabbar-Lopez, Z. K.
    Yiu, Z. Z.
    Bale, T.
    Burden, A. D.
    Coates, L. C.
    Cruickshank, M.
    Hadoke, T.
    MacMahon, E.
    Murphy, R.
    Nelson-Piercy, C.
    Owen, C. M.
    Parslew, R.
    Peleva, E.
    Pottinger, E.
    Samarasekera, E. J.
    Stoddart, J.
    Strudwicke, C.
    Venning, V. A.
    Warren, R. B.
    Exton, L. S.
    Mustapa, M. F. Mohd
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2017, 177 (03) : 628 - 636
  • [9] Risk of tuberculosis in patients treated with TNF-α antagonists: a systematic review and meta-analysis of randomised controlled trials
    Zhang, Zheng
    Fan, Wei
    Yang, Gui
    Xu, Zhigao
    Wang, June
    Cheng, Qingyuan
    Yu, Mingxia
    [J]. BMJ OPEN, 2017, 7 (03):
  • [10] The BCG World Atlas: A Database of Global BCG Vaccination Policies and Practices
    Zwerling, Alice
    Behr, Marcel A.
    Verma, Aman
    Brewer, Timothy F.
    Menzies, Dick
    Pai, Madhukar
    [J]. PLOS MEDICINE, 2011, 8 (03)
1